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In “The Pathology of Fresh and Cryopre-
served Homograft Heart Valves: An Anal-
ysis of Forty Explanted Homograft
Valves,” Koolbergen and colleagues1 at-
tempted nicely to reconstruct the sequence
of events leading to failure of homografts
from a data set of 40 explanted valves
examined histologically. Despite the limi-
tations of such a study and the significant
variability among patients, they convinc-
ingly observed a reduction in valve leaflet
cellularity that appears to occur within the
first year after implantation.
The loss of cellular elements has also
been previously reported by others, but
what remains unclear is the exact cause for
this loss of donor cells.2,3 Although it is
clear is that some immune cell infiltration
can be demonstrated, as well as evidence of
donor-specific immune activation, a direct
causal relationship remains difficult to
prove. In this article Koolbergen and col-
leagues1 described some early infiltration
of immune effector cells, such as macro-
phages and T lymphocytes. This observa-
tion may in fact represent evidence of im-
mune-related valve injury, despite the
absence of up-regulation of cell adhesion
molecules, because the timing for up-regu-
lation of cell adhesion molecules may be
quite difficult to detect and impossible to
evaluate with certainty in this type of anal-
ysis.
What is particularly interesting about
this loss of cellular elements is that sim-
ilar findings have been duplicated in a rat
model of allograft failure, in which valve
leaflet cellularity was demonstrated to be
significantly reduced with time.4 In this
rat model immune-specific cells (T lym-
phocytes) were recruited in allografts, re-
sulting in apoptotic cell death of donor
cellular elements.4 The entire process
was absent in syngeneic valves and could
be inhibited by T-cell immunosuppres-
sion and cell adhesion molecule block-
ade, suggesting that allograft valve fail-
ure is at least in part immune mediated.4,5
Most of the evidence for immune-medi-
ated damage in this model occurred in the
first 2 weeks after implantation, and by 4
weeks the valves were largely acellular.
It is not surprising then that Koolbergen
and colleagues1 could find little evidence
of immune-mediated injury— despite
showing, in the valve explanted at 2
weeks, an obvious T-cell infiltrate. Any
such injury almost certainly had to have
occurred before the majority of these
valves were explanted (median 4 years).
The contribution of cellular elements to
the homograft survival appears poor, as
suggested by their significant disappear-
ance early after implantation. Taken to-
gether, a homograft with less viable cellu-
lar elements and well-preserved
ultrastructure may be ideal in provoking
the least donor-specific immune response
and therefore contributing to limited valve
injury after implantation. This finding sup-
ports current efforts to create a cell-free or
nonimmunogenic homograft for clinical
use.6
Jean Francois Le´gare´, MD
Dalhousie University
Halifax, Nova Scotia, Canada
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Obstruction of St Jude Medical
valves in the aortic position
To the Editor:
I enjoyed the recent article by Teshima and
coworkers, “Obstruction of St Jude Medi-
cal Valves in the Aortic Position: Histology
and Immunohistochemistry of Pannus”
(J Thorac Cardiovasc Surg. 2003;126:401-
7). I recently reoperated on 2 young female
patients with dysfunction of St Jude Med-
ical prosthetic valves (St Jude Medical, Inc,
St Paul, Minn) in the aortic position. Both
patients had moderate amounts of pannus
formation on the valve. Both patients had
significant periods during their postopera-
tive management when anticoagulation
was discontinued or inadequate. Perhaps
more significantly, they had small aortic
roots. The explanted St Jude Medical
valves were 19 mm in both patients.
Are young female patients who receive
19- or 21-mm implants for small aortic
roots predisposed toward pannus forma-
tion? Is pannus formation detected only in
19- and 21-mm valves, in which a minor
reduction in orifice area may result in clin-
ically apparent hemodynamic deteriora-
tion? I noticed the female predilection in
the published series and wondered about
the size of the explanted prostheses and if
the postimplantation coagulation history of
these patients was known.
Frank A. Baciewicz, Jr, MD





Reply to the Editor:
We read with interest the letter by Dr Ba-
ciewicz regarding his experience of two
Thyoung female patients with prosthetic valve
dysfunction as a result of pannus forma-
tion. In our study, we showed histologic
and immunohistochemical findings of pan-
nus tissue that caused prosthetic valve dys-
function after aortic valve replacement. We
believe that our study provides information
useful to elucidate the mechanisms of pan-
nus formation in patients receiving pros-
thetic valves. We also think, however, that
our findings are not sufficient to reach con-
clusion regarding the complete pathoge-
netic mechanisms of this disorder, and fur-
ther prospective studies including more
patients and control specimens are re-
quired.
The sizes of the prosthesis explanted in
this study were 21 mm in 6 patients (all
female), 23 mm in 2 (1 male and 1 female),
25 mm in 1 (male), and 27 mm in 1 (male).
The ratio of effective orifice area (accord-
ing to the manufacturer’s report) to body
surface area, as an index of patient-pros-
thesis mismatch, in our patients with pan-
nus receiving 21-mm prostheses was 1.0 
0.1 cm2. The ratio was slightly lower than
that in patients with normally functioning
21-mm aortic prostheses (1.2  0.2 cm2).1
Because remaining significant transvalvu-
lar gradient after valve replacement may
induce shear stress at the periannular tis-
sue, patient-prosthesis mismatch per se can
be a cause of excessive intimal growth.
Another important issue in patients with
small aortic annuli is mechanical contact
between the ventricular septum and the
pivot guard of the prosthesis. It is conceiv-
able that the pivot guard protrudes to the
left ventricular side, which is unique to the
design of St Jude Medical valves,2 and thus
is readily in contact with the hypertrophied
ventricular septum. Recently, we carefully
examined patients with prosthetic valve
dysfunction in the aortic position with mul-
tidetector row computed tomography.3 In
that study, these pathognomic conditions
and pannus formation located mainly on
the pivot guard of the septal side were
confirmed. Therefore the possibility exists
that patients with small aortic annuli are
predisposed toward pannus formation re-
gardless of the absence of patient-prosthe-
sis mismatch, especially when the patient
has a small left ventricular outflow tract.
During the period of this study, 615
patients underwent aortic valve replace-
ment with St Jude Medical valves, and 265
e Journal of Thoracic and Cardiovascular Sof those were female (43%). Therefore, as
indicated by Dr Baciewicz, the female pro-
portion of patients who had prosthetic
valve dysfunction develop tended to be
higher than that of patients with normal
prosthetic valve function. A major reason
for this appears to be simply that female
patients had smaller aortic annulus diame-
ters. The mean age of our 7 female patients
who developed pannus formation was 62.6
 6.7 years, which did not differ from our
265 female patients with normally func-
tioning aortic valve prostheses. Although
the number of patients is small and our
results do not have statistical power, pa-
tient age per se may not be an important
factor in pannus formation.
In our study, 4 of 11 patients with pros-
thetic valve dysfunction had a short-term
history of warfarin withdrawal during treat-
ments for noncardiac disease (abdominal
operations and dental treatment). The re-
maining 7 patients received adequate anti-
coagulation therapy with warfarin through-
out the postoperative period. The
observations during reoperations and histo-
logic examinations of periannular tissue
did not demonstrate thrombus in all pa-
tients. These findings, however, do not ne-
gate the presence of perivalvular thrombus
at an earlier period of prosthetic valve dys-
function. Because pannus can develop as a
result of prosthetic valve thrombosis, inad-
equate anticoagulation also is considered to
be a risk factor for this disorder.
The cause of prosthetic valve dysfunc-
tion related to pannus may be multifacto-
rial, and definitive mechanisms for this dis-
order have not yet been conclusively
shown. On the basis of our findings that
excessive expression of transforming
growth factor  was observed in the pan-
nus, however, chronic inflammatory reac-
tion in the periannular lesions—perhaps as
a result of surgical trauma, reaction to the
foreign materials, mechanical contact, in-
adequate anticoagulation, and shear stress
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